ImmunityBio
IBRX
IBRX
58 hedge funds and large institutions have $113M invested in ImmunityBio in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 60 → 58 (-2)
27% less call options, than puts
Call options by funds: $1.49M | Put options by funds: $2.04M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
58
Holding in Top 10
1
Calls
$1.49M
Puts
$2.04M
Top Buyers
| 1 | +$5.21M | |
| 2 | +$933K | |
| 3 | +$895K | |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$563K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$404K |
Top Sellers
| 1 | -$8.3M | |
| 2 | -$4.52M | |
| 3 | -$3.01M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.11M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$841K |